World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ANZCTR
Last refreshed on: 22 January 2024
Main ID:  ACTRN12619000242123
Date of registration: 19/02/2019
Prospective Registration: Yes
Primary sponsor: Centre for Emotional Health, Macquarie University
Public title: Improving Mental Health and Social Participation Outcomes in Older Adults with Depression and Anxiety
Scientific title: Improving Mental Health and Social Participation Outcomes in Older Adults with Depression and Anxiety
Date of first enrolment: 16/07/2019
Target sample size: 172
Recruitment status: Recruiting
URL:  https://anzctr.org.au/ACTRN12619000242123.aspx
Study type:  Interventional
Study design:  Purpose: Treatment; Allocation: Randomised controlled trial; Masking: Open (masking not used);Assignment: Parallel;Type of endpoint: Efficacy;  
Phase:  Not Applicable
Countries of recruitment
Australia
Contacts
Name: Dr Jessamine Chen   
Address:  Centre for Emotional Health Department of Psychology Macquarie University Balaclava Road North Ryde NSW 2109 Australia
Telephone: +612 9850 9882
Email: jessamine.chen@mq.edu.au
Affiliation: 
Name: Prof Viviana Wuthrich   
Address:  Centre for Emotional Health Department of Psychology Macquarie University Balaclava Road North Ryde NSW 2109 Australia
Telephone: +612 9850 4866
Email: viviana.wuthrich@mq.edu.au
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria: Older adults aged 65 years of older
Primary anxiety and/or unipolar depressive disorder as assessed by the Anxiety Disorders Interview Schedule (ADIS-V).

Exclusion criteria: English language illiteracy, psychosis or bipolar disorder, active suicidality, significant uncorrected hearing loss and likely moderate to severe dementia based on a standardised cognitive screener test (i.e. the scores on the six-item Cognitive impairment Screener).

Age minimum: 65 Years
Age maximum: No limit
Gender: Both males and females
Health Condition(s) or Problem(s) studied
Anxiety;Depression;
Anxiety
Depression
Mental Health - Anxiety
Mental Health - Depression
Intervention(s)
A one-hour one-on-one session per week for 12 weeks using manualised CBT based on the empirically validated CBT program for older age anxiety and depression, Ageing Wisely. The enhanced CBT program teaches the same CBT skills as the standard CBT program, but with a stronger focus on bolstering social participation and connections within those skills. That is, in the enhanced CBT program, standard CBT techniques such as goal setting, activity scheduling, and graded exposure, are specifically focused around social connections, maximising family and community support, and social contribution. Modules of social connection are integrated into the standard CBT program and module length varies from session to session.

Treatment is delivered by Clinical Psychologists and Clinical Psychology registrars, supervised by Chief Investigators to ensure treatment adherence. Adherence of participants to treatment will be monitored with 20% of the sessions coded for fidelity by an independent rater.
Primary Outcome(s)
Mean Clinician’s Severity Rating of anxiety and mood disorders based on the Anxiety and Related Disorders Interview Schedule 5th edition (ADIS-V) posttreatment.[ 14 weeks from baseline assessment.]
Secondary Outcome(s)
Change in The Lubben Social Network Scale total score.[ 14 weeks from baseline assessment and 12 months from start of therapy.]
Change in the iMTA Productivity Cost Questionnaire total score.[ 14 weeks from baseline assessment and 12 months from start of therapy.]
Change in De Jong Gierveld Loneliness Scales total score.[ 14 weeks from baseline assessment and 12 months from start of therapy.]
Change in Geriatric Anxiety Scale total score.[ 14 weeks from baseline assessment and 12 months from start of therapy.]
Change in Clinician’s Severity Rating of anxiety disorders based on the ADIS-V.[ 12 months from start of therapy.]
Change in the Australian Quality of Life total score.[ 14 weeks from baseline assessment and 12 months from start of therapy.]
Change in the Australian Community Participation Questionnaire short form total score.[ 14 weeks from baseline assessment and 12 months from start of therapy.]
Change in Geriatric Anxiety Inventory total score.[ 14 weeks from baseline assessment and 12 months from start of therapy.]
Change in the Bille- Brahe Social Support Scale total score.[ 14 weeks from baseline assessment and 12 months from start of therapy.]
Change in Depressive Symptoms Inventory – Suicide Subscale score.[ 14 weeks from baseline assessment and 12 months from start of therapy.]
Change in Geriatric Depression Scale total score.[ 14 weeks from baseline assessment and 12 months from start of therapy.]
Change in Use of Service Questionnaire total score. This purpose built medical cost questionnaire was designed specifically for this study.[ 14 weeks from baseline assessment and 12 months from start of therapy.]
Secondary ID(s)
NIL
Source(s) of Monetary Support
Beyond Blue
National Health and Medical Research Council
Secondary Sponsor(s)
Ethics review
Status: Approved
Approval date: 24/01/2019
Contact:
Macquarie University Human Research Ethics Committee Medical Sciences
Status: Not approved
Approval date:
Contact:
Centre for Health Record Linkage Ethics Committee
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history